Help Patients With Skyrocketing Insulin Costs

August 2019

One in four patients with diabetes will ration or even stop their insulin due to skyrocketing costs...sometimes leading to death.

In the U.S., only 3 companies make insulin...driving up prices.

You'll see more efforts to address costs...such as co-pay caps from some payers and states. And FDA is exploring ways to promote competition.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Photosensitivity Identify and Manage Med-Induced Photosensitivity
Insulin Help Patients With Skyrocketing Insulin Costs
Compounding Be Ready for Non-Sterile Compounding Changes With USP 795 Updates
Opioids Don't Think of Tramadol as a "Safer" Opioid
Pregnancy Weigh OTC Options for Treating GI Issues in Pregnancy
Antimalarials Add Arakoda to Your List of Malaria Prophylaxis Options
Diabetes Consider Cardiovascular Benefits When Recommending a GLP-1 Agonist
HIV & AIDS Know How to Manage Dyslipidemia in Patients Living With HIV
Lupus Be Familiar With Nuances for Managing Lupus
Patient Safety Tell Patients to Avoid Unsafe Stem Cells
Compounding Expect USP 797 to Impact Sterile Compounding